Lista de obras -

Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract

artículo científico publicado en 2016

Alvimopan for recovery of bowel function after radical cystectomy

artículo científico publicado en 2018

Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort

artículo científico publicado en 2014

Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

artículo científico

Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract

artículo científico publicado en 2014

Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses

artículo científico publicado en 2017

Discordance Between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma

artículo científico publicado en 2018

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer

artículo científico publicado en 2016

Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma

artículo científico publicado en 2013

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer

artículo científico publicado en 2016

Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone

artículo científico publicado en 2013

Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma

artículo científico publicado en 2014

Impact of hospital case volume on testicular cancer outcomes and practice patterns

artículo científico publicado en 2017

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence

artículo científico publicado en 2016

Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy

artículo científico

Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate

artículo científico publicado en 2016

Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

artículo científico publicado en 2015

Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?

artículo científico publicado en 2015

Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma

artículo científico publicado en 2015

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract

artículo científico publicado en 2014

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer

artículo científico publicado en 2014

Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort

artículo científico publicado en 2014

Organ Preservation is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma - Results of a Comprehensive Multicenter Study

artículo científico

Partial nephrectomy versus radical nephrectomy for clinically localized renal masses

artículo científico publicado en 2016

Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience

artículo científico publicado en 2013

Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma

artículo científico publicado en 2016

Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence

artículo científico publicado en 2018

Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus

artículo científico publicado en 2015

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

artículo científico publicado en 2016

Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC).

artículo científico publicado en 2015

Prognostic Implications of Immunohistochemical Biomarkers in Non-Muscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer.

artículo científico publicado en 2016

Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2015

Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma

artículo científico publicado en 2017

Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma

artículo científico publicado en 2013

Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma

artículo científico publicado en 2017

Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma

artículo científico publicado en 2013

Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?

artículo científico publicado en 2013

Prospects and progress of immunotherapy for bladder cancer

artículo científico publicado en 2017

Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis

artículo científico publicado en 2015

Should patients newly diagnosed with bladder cancer be screened for lung cancer?

artículo científico publicado en 2016

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

scientific article published on 09 March 2017

Surgical management of metastatic renal cell carcinoma in the era of targeted therapies

artículo científico publicado en 2014

Surgical management of renal cell carcinoma

artículo científico publicado en 2014

Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature

artículo científico publicado en 2014

TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma

artículo científico publicado en 2015

The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus

The Rho GTPase signalling pathway in urothelial carcinoma

artículo científico publicado en 2017

The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone

artículo científico publicado en 2017

The safety and efficacy of gemcitabine for the treatment of bladder cancer

artículo científico publicado en 2016

The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors ⬇️

artículo científico publicado el 1 de septiembre de 2013

Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis

artículo científico publicado en 2017

Lista de obras de

Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract

Alvimopan for recovery of bowel function after radical cystectomy

Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort

Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract

Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses

Discordance Between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer

Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer

Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone

Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma

Impact of hospital case volume on testicular cancer outcomes and practice patterns

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence

Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy

Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate

Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?

Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer

Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort

Organ Preservation is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma - Results of a Comprehensive Multicenter Study

Partial nephrectomy versus radical nephrectomy for clinically localized renal masses

Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience

Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma

Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence

Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC).

Prognostic Implications of Immunohistochemical Biomarkers in Non-Muscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer.

Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma

Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma

Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma

Prognostic value of tissue-based biomarker signature in clear cell renal cell carcinoma

Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma

Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?

Prospects and progress of immunotherapy for bladder cancer

Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis

Should patients newly diagnosed with bladder cancer be screened for lung cancer?

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Surgical management of metastatic renal cell carcinoma in the era of targeted therapies

Surgical management of renal cell carcinoma

Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature

TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma

The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus

The Rho GTPase signalling pathway in urothelial carcinoma

The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone

The safety and efficacy of gemcitabine for the treatment of bladder cancer

The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors ⬇️

Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis